Invex Therapeutics Ltd. (AU:IXC) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Invex Therapeutics Ltd. has announced the expiration of 400,000 options on April 8, 2024, without exercise or conversion. The options were set to expire at a strike price of $0.91. This development may influence the company’s capital structure and potentially impact shareholder value.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.